ICAM1 and neoplasm: The anergy of tumor endothelial cells and the loss of leukocyte-endothelial cell adhesion in vitro is the direct result of ICAM-1 down-regulation, the silencing is also regulated by the aforementioned modulation of the histone modification profile [64].